PADVa n = 437 | Population-based n = 643 | |
---|---|---|
Age (years) | 70.0 ± 7.2 | 66.2 ± 9.5 |
Female sex | 179 (41.0%) | 192 (29.9%) |
Ever smoked | 331 (75.9%) | 350(54.4%) |
Body mass index (kg/m2) | 27.1 ± 4.2 | 26.6 ± 3.6 |
Hypertension | 336 (77.4%) | 226 (35.1%) |
Diabetes mellitus | 110 (25.2%) | 45 (7.0%) |
Myocardial infarction | 80 (18.3%) | 21 (3.2%) |
TIA/Stroke | 44 (10.1%) | 25 (3.9%) |
Total cholesterol (mmol/L) | 4.6 ± 1.2 | 5.6 ± 1.1 |
Creatinine (umol/L) | 81 (69–97) | 79 (69–90) |
HbA1c (mmol/mol) | 42.5 ± 10.7 | 37.9 ± 7.1 |
ICA stenosis | – | |
No stenosis | 22 (0.5%) | – |
30–50% stenosis | 196 (44.9%) | – |
50–70% stenosis | 70 (16.0%) | – |
> 70% stenosis/occlusion | 62 (14.2%) | – |
Abnormal ABI | 255 (58.4%) | – |
LVEF < 45% | 24 (5.5%) | 11 (1.7%) |
Medication | ||
ACE-I | 153 (35.1%) | 73 (11.4%) |
Statin | 354 (81.2%) | 111 (17.3%) |
Aspirin | 338 (77.5%) | 117 (18.2%) |
Betablocker | 224 (51.4%) | 130 (20.2%) |
GDF-15 (NPX) | 10.1 (9.6–10.6) | 9.5(9.1–10.0) |
GDF-15 (ng/L) | 1379 (979–2083) | 1027 (762–1377) |
NT-proBNP (NPX) | 5.1 (4.0–6.0) | 3.7 (2.8–4.6) |
NT-proBNP (ng/L) | 169 (89–345) | 77 (40–148.5) |